Lupus Fatigue Research: 2025 Catalyst Award Winner Announced

2025 Catalyst Award:

Advancing Lupus Fatigue Research with Dr. Mohamed Osman

Dr. Mohamed Osman to Investigate the Biological Causes of Fatigue in Lupus

Portrait of Dr. Mohamed Osman, 2025 Lupus Canada Catalyst Award recipient, recognized for his work in lupus fatigue research at the University of Alberta.

Lupus Canada and the Lupus Foundation of America are proud to announce Dr. Mohamed Osman, MD, PhD, of the University of Alberta as the recipient of the 2025 Lupus Canada Catalyst Award. His study will focus on understanding the biological mechanisms behind one of the most debilitating symptoms of lupus: fatigue.

Why This Research Matters

Fatigue affects nearly all people living with lupus, often regardless of disease activity. It is frequently paired with pain and cognitive issues such as brain fog, yet the biological cause of these symptoms remains unclear. Dr. Osman’s research will investigate whether markers of inflammation and oxidative stress contribute to this chronic fatigue.

The goal: to help uncover pathways that may lead to improved testing and future treatment strategies.

Project Title: Defining the Molecular Drivers of Fatigue in Lupus: A Pilot Study

Institution: Governors of the University of Alberta

Summary: This pilot study will compare lupus patients with severe fatigue, pain, and brain fog to those without these symptoms, as well as healthy volunteers and individuals with fibromyalgia. By analyzing blood samples from three lupus clinics across Canada, Dr. Osman hopes to identify inflammation-related biomarkers that contribute to fatigue and cognitive dysfunction in lupus.

Read More

Learn More About the Catalyst Grant

The Lupus Canada Catalyst Grant provides one-year funding to Canadian researchers pursuing novel studies aimed at improving quality of life for people with lupus.

Lupus Blog Articles:

Lupus Fatigue Research: 2025 Catalyst Award Winner Announced

Read

Lupus Research Fundraising: Help Cultivate a Life Without Lupus This Spring

Read

Lupus Treatment and Access Across Provinces: Take the Patient Survey

Read